I agree that this site is using cookies. You can find further informations here.
X
Dilly, Jason S.
107  results:
Search for persons X
?
1

Inadvertent Trypan Blue Staining of Posterior Capsule durin..:

Prinzi, Robert A. ; Alapati, Neeti M. ; Gappy, Shawn S..
Case Reports in Ophthalmological Medicine.  2016 (2016)  - p. 1-3 , 2016
Link: https://doi.org/10.1155/..
 
?
2

Autoenucleation of a Blind Eye:

Dilly, Jason S. ; Imes, Richard K.
Journal of Neuro-ophthalmology.  21 (2001)  1 - p. 30-31 , 2001
Link: https://doi.org/10.1097/..
 
?
3

Inadvertent Trypan Blue Staining of Posterior Capsule durin..:

Robert A. Prinzi ; Neeti M. Alapati ; Shawn S. Gappy.
http://dx.doi.org/10.1155/2016/9025063.  , 2016
Link: https://doi.org/10.1155/..
 
?
4

Supplementary Table S12 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558724.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
5

Supplementary Table S4 from Oncogenic Drivers and Therapeut..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558694.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
6

Supplementary Figure S8 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558739.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
7

Supplementary Figure S6 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558748.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
8

Supplementary Figure S4 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558754.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
9

Supplementary Figure S10 from Oncogenic Drivers and Therape..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558766.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
10

Supplementary Table S18 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558703.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
11

Supplementary Table S5 from Oncogenic Drivers and Therapeut..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558691.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
12

Supplementary Table S8 from Oncogenic Drivers and Therapeut..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558682.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
13

Supplementary Figure S2 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558760.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
14

Supplementary Figure S7 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558745.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
15

Supplementary Figure S1 from Oncogenic Drivers and Therapeu..:

Harshabad Singh ; Rachel B. Keller ; Kevin S. Kapner...
doi:10.1158/1078-0432.24558769.v1.  , 2023
Link: https://doi.org/10.1158/..
 
1-15